Saver, J. L., Fonarow, G. C., Smith, E. E., Reeves, M. J., Grau-Sepulveda, M. V., Pan, W., … Schwamm, L. H. (2013). Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population. In STROKE (Vol. 44). Honolulu, HI: LIPPINCOTT WILLIAMS & WILKINS.

Saver, Jeffrey L., Gregg C. Fonarow, Eric E. Smith, Mathew J. Reeves, Maria V. Grau-Sepulveda, Wenqin Pan, DaiWai Olson, Adrian F. Hernandez, Eric D. Peterson, and Lee H. Schwamm. “Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population.” In STROKE, Vol. 44. LIPPINCOTT WILLIAMS & WILKINS, 2013.

Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, et al. Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population. In: STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2013.

Saver, Jeffrey L., et al. “Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population.” STROKE, vol. 44, no. 2, LIPPINCOTT WILLIAMS & WILKINS, 2013.

Saver JL, Fonarow GC, Smith EE, Reeves MJ, Grau-Sepulveda MV, Pan W, Olson D, Hernandez AF, Peterson ED, Schwamm LH. Time to Treatment with Intravenous Tissue Plasminogen Activator and Outcome from Acute Ischemic Stroke in the National US GWTG-Stroke Population. STROKE. LIPPINCOTT WILLIAMS & WILKINS; 2013.